南华生物
(000504)
| 流通市值：36.50亿 | | | 总市值：36.60亿 |
| 流通股本：3.29亿 | | | 总股本：3.30亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 308,965,483.03 | 183,374,413.22 | 346,768,170.11 | 162,818,548.64 |
| 交易性金融资产 | - | 120,000,583.03 | - | 100,456,626 |
| 应收票据及应收账款 | 199,432,943.12 | 350,586,689.91 | 320,479,476.74 | 143,513,365.48 |
| 其中：应收票据 | 58,847,892.41 | 186,311,545.08 | 101,958,952.44 | 5,300,000 |
| 应收账款 | 140,585,050.71 | 164,275,144.83 | 218,520,524.3 | 138,213,365.48 |
| 预付款项 | 28,616,959.09 | 26,741,689.45 | 15,630,255.18 | 15,257,131.58 |
| 其他应收款合计 | 18,638,169.54 | 17,652,512.15 | 18,021,005.54 | 24,013,242.66 |
| 存货 | 53,565,715.74 | 48,538,088.3 | 18,665,612.89 | 46,254,810.61 |
| 其他流动资产 | 22,995,338.7 | 20,162,236.68 | 19,355,287.56 | 25,123,158.83 |
| 流动资产合计 | 632,214,609.22 | 767,056,212.74 | 738,919,808.02 | 517,436,883.8 |
| 非流动资产: | | | | |
| 固定资产 | 161,155,551.02 | 163,516,792 | 165,435,181.41 | 148,431,703.5 |
| 在建工程 | 2,282,225.6 | 1,381,954.45 | 108,075.33 | 19,519,761.87 |
| 使用权资产 | 3,562,185.89 | 4,180,077.71 | 4,677,762.89 | 8,508,211.67 |
| 无形资产 | 54,155,225.89 | 55,549,826.18 | 55,811,301.22 | 62,365,426.98 |
| 商誉 | 6,226,910.53 | 6,226,910.53 | 6,226,910.53 | 1,983,226.77 |
| 长期待摊费用 | 8,792,205.62 | 9,803,899.4 | 10,833,889.63 | 75,395,629.43 |
| 递延所得税资产 | 12,146,328.01 | 8,708,420.46 | 8,708,420.46 | 8,280,946.43 |
| 其他非流动资产 | 697,777.62 | - | 1,009,654.27 | 34,185.07 |
| 非流动资产合计 | 249,018,410.18 | 249,367,880.73 | 252,811,195.74 | 324,519,091.72 |
| 资产总计 | 881,233,019.4 | 1,016,424,093.47 | 991,731,003.76 | 841,955,975.52 |
| 流动负债: | | | | |
| 短期借款 | 153,187,339.72 | 278,407,812.64 | 270,254,392.59 | 43,041,722.22 |
| 应付票据及应付账款 | 21,818,172.51 | 14,395,013.11 | 14,715,783.6 | 94,693,650.09 |
| 其中：应付票据 | - | - | - | 11,424,016.81 |
| 应付账款 | 21,818,172.51 | 14,395,013.11 | 14,715,783.6 | 83,269,633.28 |
| 预收款项 | - | - | - | 21,895.84 |
| 合同负债 | 223,914,180.39 | 206,833,526.31 | 201,445,948.34 | 194,605,702.35 |
| 应付职工薪酬 | 3,349,905.77 | 3,953,171.65 | 7,739,934.25 | 3,227,495.57 |
| 应交税费 | 4,209,213.77 | 4,354,752.91 | 15,358,316.65 | 2,702,493.75 |
| 其他应付款合计 | 4,228,515.69 | 21,498,369.94 | 8,511,967.53 | 8,090,172.42 |
| 应付股利 | 931,102.81 | 931,102.81 | 931,102.81 | 931,102.81 |
| 一年内到期的非流动负债 | 8,646,435.87 | 13,099,091.09 | 14,801,206.97 | 1,580,959.99 |
| 其他流动负债 | 15,261,956.3 | 12,223,756.48 | 12,327,796.48 | 16,393,819.61 |
| 流动负债合计 | 434,615,720.02 | 554,765,494.13 | 545,155,346.41 | 364,357,911.84 |
| 非流动负债: | | | | |
| 长期借款 | 52,950,000 | 52,950,000 | 52,950,000 | 75,485,000 |
| 租赁负债 | 2,159,676.06 | 5,225,889.34 | 3,235,879.48 | 9,676,004.43 |
| 递延收益 | 26,729,229.72 | 27,304,549.12 | 26,641,263.45 | 23,152,257.04 |
| 递延所得税负债 | 5,917,058.83 | 6,242,222.94 | 6,242,192.96 | 6,628,814.59 |
| 其他非流动负债 | - | 863,767.78 | - | - |
| 非流动负债合计 | 87,755,964.61 | 92,586,429.18 | 89,069,335.89 | 114,942,076.06 |
| 负债合计 | 522,371,684.63 | 647,351,923.31 | 634,224,682.3 | 479,299,987.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,023,098 | 330,023,098 | 330,023,098 | 330,023,098 |
| 资本公积 | 423,300,174.6 | 423,300,174.6 | 423,300,174.6 | 423,472,870.01 |
| 盈余公积 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 |
| 未分配利润 | -516,125,141.83 | -511,017,154.16 | -522,117,836.05 | -545,714,187.56 |
| 归属于母公司股东权益合计 | 271,743,864.95 | 276,851,852.62 | 265,751,170.73 | 242,327,514.63 |
| 少数股东权益 | 87,117,469.82 | 92,220,317.54 | 91,755,150.73 | 120,328,472.99 |
| 股东权益合计 | 358,861,334.77 | 369,072,170.16 | 357,506,321.46 | 362,655,987.62 |
| 负债和股东权益合计 | 881,233,019.4 | 1,016,424,093.47 | 991,731,003.76 | 841,955,975.52 |
| 公告日期 | 2026-08-24 | 2026-04-29 | 2026-04-29 | 2025-10-27 |
| 审计意见(境内) | | | 标准无保留意见 | |